slides · global inventory
Paragraph
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 118,471
Current window 4,831-4,860
Pages 3,950
Rows per page 30
Component
4,831-4,860 of 118,471
10
The slide uses a quote from a former employee and a direct excerpt from Google's policy to support its bearish thesis.Skillz, Inc. (SKLZ) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction5 hits
160
The slide highlights the FDA's 'wait-and-see' posture and specific concerns about seizures as a safety signal for the drug pitolisant.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 5 hits
228
The slide highlights a recurring methodological inconsistency across multiple clinical trials, suggesting regulatory oversight failure.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 5 hits
267
The slide uses highlighted text to emphasize aggressive prescribing behavior and high patient penetration rates.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 5 hits
269
The slide uses highlighted text to emphasize the doctor's lack of due diligence and surprise at the drug's high cost.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 5 hits
77
Uses a direct quote from a 2020 trade article to expose the company's marketing claims.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 5 hits
112
The slide uses a Q&A format to highlight technical failures and high replacement costs (millions of dollars) for optical components.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 5 hits
140
The slide uses direct quotes from a former KLA executive to validate the thesis regarding the inherent contamination risks in EUV inspection systems.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 5 hits
157
The slide presents a Q&A format to highlight potential technical failures and lack of transparency regarding Lasertec's supply chain choices.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 5 hits
175
The slide contains repetitive text blocks, likely drafts or variations of the same narrative regarding Lasertec's technical struggles with Energetiq and Ushio light sources.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 5 hits
270
The slide uses a transcript-style format to contrast past management skepticism with the current reality of the market.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 5 hits
291
The slide presents expert testimony defending KLA's non-actinic inspection technology against competitors.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 5 hits
07
The slide argues that Lasertec's inventory classification (0% finished goods) is a deliberate accounting trick to avoid impairment charges and maintain stock price, supported by anecdotal evidence from IR and photographic evidence.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · Problem & ComplicationLoop · Logic Chain5 hits
24
Contains specific allegations regarding Lasertec's supply chain, Isteq's origins, and technical failures of the plasma-based light source.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · Problem & ComplicationLoop · Logic Chain5 hits
32
The slide presents qualitative evidence from interviews with industry executives regarding TSMC's reliance on and dissatisfaction with Lasertec's ACTIS series equipment.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · Problem & ComplicationLoop · Logic Chain5 hits
33
TSMCの元幹部へのインタビューを通じた、レーザーテックに対する否定的な見解とKLAへのシフトの背景。Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · Problem & ComplicationLoop · Logic Chain5 hits
58
Uses excerpts from a press release and a clinical paper to highlight study design flaws.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The VictoryLoop · Cost Of Inaction5 hits
128
The slide uses yellow highlighting to emphasize key negative feedback points from the former employee.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory5 hits
27
The slide uses a Q&A format to highlight a specific technical discrepancy in a battery performance chart.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technologyLoop · Aha Moment5 hits
86
The slide uses a Q&A format to highlight the contradiction between the company's presented data and the expected physical behavior of the battery technology.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology5 hits
121
The slide uses a direct quote from a medical paper to highlight a discrepancy between the company's claim and the reported data.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 5 hits
124
The slide uses a red box to highlight the specific claim about 60% of participants having PD/DM at baseline.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 5 hits
232
The slide uses a Q&A format to highlight potential corporate malfeasance regarding safety data reporting.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 5 hits
266
Uses press release excerpts to establish a pattern of behavior or conflict of interest.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 5 hits
340
The slide presents a transcript of an expert consultation call to undermine the market potential of Vykat.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 5 hits
389
The slide uses a Q&A format to highlight expert skepticism regarding the drug's necessity and cost-effectiveness.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 5 hits
06
This appears to be a page from an activist short report or regulatory challenge document.Soleno Therapeutics (SLNO) · Kir Kahlon
Regulatory filing Short seller Beat · Desire5 hits
52
The slide uses Q&A transcripts to highlight forced reliance on third-party technicians and procurement teams, which the experts view as a significant operational drawback.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 5 hits
260
The slide uses a Q&A format to build a case against the company's business practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 5 hits
267
The slide uses a combination of summary text and direct interview transcripts to build a case of corporate misconduct.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 5 hits